EUVIMEDOpdag EUVIMED
Crossref

Prunetin Protects Against Sepsis‐Induced Acute Lung Injury by Inhibiting Inflammation and Oxidative Stress via Regulating the TLR4 / NF ‐ κB / NLRP 3 Inflammasome Pathway

Xuedong Zhang, Siqi Dai, Chaojie Li, Tu Shen iD, Fengxiang Zhang iD

Chemical Biology & Drug Design · 2026-04 · 107 (4)

DOI: 10.1111/cbdd.70301 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2026-04-24. Written by Xuedong Zhang and 4 co-authors. Institution: Department of Critical Care Medicine, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. Major MEDLINE topics: Acute Lung Injury, Oxidative Stress, Sepsis, Inflammasomes. 44 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Prunetin is a naturally occurring flavonoid with effective therapeutic potential against diverse diseases. This study aimed to investigate the potential properties of prunetin in alleviating lipopolysaccharide (LPS)‐induced inflammatory responses and oxidative stress in an acute lung injury (ALI) mouse model and murine alveolar macrophages (MH‐S cells). The results showed that prunetin protected against LPS‐induced ALI in mice, as shown by improved histopathological alterations in lung tissues, reduced lung injury score, and decreased lung wet/dry weight ratio. Furthermore, prunetin attenuated LPS‐induced inflammatory responses and oxidative stress both in vivo and in vitro. Prunetin treatment attenuated LPS‐induced increase in the expression of toll‐like receptor 4 (TLR4), phosphorylated nuclear factor kappa B (NF‐κB) p65, nuclear p65, NLR family pyrin domain containing 3 (NLRP3), and ASC, implying that prunetin inhibited LPS‐induced activation of the TLR4/NF‐κB/NLRP3 inflammasome pathway. Moreover, TLR4 overexpression abolished the inhibitory effects of prunetin on LPS‐induced inflammatory responses and oxidative stress in MH‐S cells. In summary, our results suggested that prunetin protected against LPS‐induced ALI through inhibiting inflammation and oxidative stress via regulating the TLR4/NF‐κB/NLRP3 inflammasome pathway. These results support that prunetin may serve as a promising agent for the treatment of sepsis‐related ALI.

Subjects

MeSH terms (MEDLINE)

Acute Lung InjuryOxidative StressSepsisInflammasomesAnimalsToll-Like Receptor 4NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinMiceLipopolysaccharidesMaleInflammationSignal TransductionMice, Inbred C57BLMacrophages, AlveolarIsoflavones

Author keywords

acute lung injuryinflammationoxidative stressprunetinsepsis

Substances

Toll-Like Receptor 4NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinLipopolysaccharidesInflammasomesprunetinTlr4 protein, mouseIsoflavones

Authors and institutions

  • Department of Critical Care Medicine, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
  • Department of Anesthesiology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.

ORCID profiles: Tu Shen, Fengxiang Zhang

Cite

APA

Zhang, X., Dai, S., Li, C., Shen, T., & Zhang, F. (2026). Prunetin Protects Against Sepsis‐Induced Acute Lung Injury by Inhibiting Inflammation and Oxidative Stress via Regulating the TLR4 / NF ‐ κB / NLRP 3 Inflammasome Pathway. Chemical Biology & Drug Design, 107(4). https://doi.org/10.1111/cbdd.70301

Vancouver

Zhang X, Dai S, Li C, Shen T, Zhang F. Prunetin Protects Against Sepsis‐Induced Acute Lung Injury by Inhibiting Inflammation and Oxidative Stress via Regulating the TLR4 / NF ‐ κB / NLRP 3 Inflammasome Pathway. Chemical Biology & Drug Design. 2026;107(4). doi:10.1111/cbdd.70301

BibTeX
@article{Zhang2026,
  author = {Zhang, Xuedong and Dai, Siqi and Li, Chaojie and Shen, Tu and Zhang, Fengxiang},
  title = {Prunetin Protects Against Sepsis‐Induced Acute Lung Injury by Inhibiting Inflammation and Oxidative Stress via Regulating the TLR4 / NF ‐ κB / NLRP 3 Inflammasome Pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {4},
  doi = {10.1111/cbdd.70301}
}
Start for free →